Volumetric absorptive microsampling for the therapeutic drug monitoring of everolimus in patients who have undergone liver transplant

Orphan drug designation: a comparison of regulatory systems among United States, European Union, and Republic of Korea

Appropriate starting dose of dasatinib based on the analyses of dose limiting toxicities and molecular responses in Asian patients with chronic myeloid leukemia

Development of a limited sampling strategy for the estimation of isoniazid exposure considering N-acetyltransferase 2 genotypes in Korean patients with tuberculosis

Development of a dried blood spot sampling method towards therapeutic monitoring of radotinib in the treatment of chronic myeloid leukaemia

Population pharmacokinetics of vactosertib, a new new TGF-β receptor type I inhibitor, in patients with advanced solid tumors

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study

Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia

Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of antituberculosis drug-induced liver injury: a systematic review and meta-analysis

Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia